Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 9;39(8):1034-1036.
doi: 10.1016/j.ccell.2021.07.016. Epub 2021 Jul 27.

Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer

Sidse Ehmsen  1 , Anders Asmussen  2 , Stefan S Jeppesen  1 , Anna Christine Nilsson  3 , Sabina Østerlev  4 , Hanne Vestergaard  2 , Ulrik S Justesen  5 , Isik S Johansen  6 , Henrik Frederiksen  7 , Henrik J Ditzel  8
Affiliations

Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer

Sidse Ehmsen et al. Cancer Cell. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of interests All authors declare no competing interests.

Comment in

  • Humoral and cellular immune responses in SARS-CoV-2 mRNA-vaccinated patients with cancer.
    Mairhofer M, Kausche L, Kaltenbrunner S, Ghanem R, Stegemann M, Klein K, Pammer M, Rauscher I, Salzer HJF, Doppler S, Habringer A, Paar C, Kimeswenger S, Hoetzenecker W, Lamprecht B, Lee S, Schmitt CA. Mairhofer M, et al. Cancer Cell. 2021 Sep 13;39(9):1171-1172. doi: 10.1016/j.ccell.2021.08.001. Epub 2021 Aug 17. Cancer Cell. 2021. PMID: 34450047 Free PMC article. No abstract available.

References

    1. Baden L.R., El Sahly H.M., Essink B., Kotloff K., Frey S., Novak R., Diemert D., Spector S.A., Rouphael N., Creech C.B., et al. COVE Study Group Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N. Engl. J. Med. 2021;384:403–416. - PMC - PubMed
    1. Bakouny Z., Hawley J.E., Choueiri T.K., Peters S., Rini B.I., Warner J.L., Painter C.A. COVID-19 and cancer: Current challenges and perspectives. Cancer Cell. 2020;38:629–646. - PMC - PubMed
    1. Ehmsen S., Jakobsen L.H., Lendorf M.E., Eefsen R.L., Bentsen L., Knoop A.S., Aggerholm-Pedersen N., Skuladottir H., Herrstedt J., Jensen L.H., et al. Severity and 1-month outcome of SARS-CoV-2 infection in patients with solid cancers: a Danish nationwide cohort study. Acta Oncol. 2021;60:859–865. - PubMed
    1. Ewertz M., Christensen K., Engholm G., Kejs A.M., Lund L., Matzen L.E., Pfeiffer P., Storm H.H., Herrstedt J., Academy of Geriatric Cancer Research (AgeCare) Trends in cancer in the elderly population in Denmark, 1980-2012. Acta Oncol. 2016;55(Suppl 1):1–6. - PubMed
    1. Griffiths E.A., Segal B.H. Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution. Cancer Cell. 2021;39:1045–1047. doi: 10.1016/j.ccell.2021.07.001. - DOI - PMC - PubMed

Publication types